CEO
NVIGEN Inc.
Aihua Fu, Ph.D. is a nanobiotechnologist. She is the co-Founder and CEO of NVIGEN Inc., a nanobiotech startup dedicated to commercializing molecularly engineered nanoparticles for biological research, diagnostic and therapeutic applications. Before she spearheaded the founding of NVIGEN with the support of Silicon Valley investors, technologists and entrepreneurs, Aihua was a postdoc at Stanford University Center of Cancer Nanotechnology Excellence to engineer nanoparticles with enhanced properties for in vitro diagnostics and in vivo cancer imaging and drug delivery applications. Aihua received her Ph.D. from the Chemistry Department of University of California at Berkeley, where she started the strong interest in understanding and engineering the unique properties of nanoparticles to advance the personalized medicine revolution. Her nanoparticle research and product development efforts were also supported by NIH Pathway to Independence Award and SBIR Awards. Her current product development and business activities focus on NVIGEN X® – precision medicine biomarker profiling – NGS and multiomics liquid biopsy testing that allows simultaneous nanoparticle capture enabled processing of cell free DNA (ctDNA), circulating tumor cells (CTC) and protein information from the same tube of blood for highly sensitive and accurate cancer monitoring with curative intention.